• Home
  • Brochure
  • Scientific Committee
  • Speakers
  • Agenda
  • Venue
  • Contact
  • Submit Abstract
  • Register

SCIENTIFIC COMMITTEE

    view profile

    Donald A. Berry

    M.D. Anderson Cancer Center of the University of Texas, USA
    view profile

    Brandon Lucke-Wold

    University of Florida, USA
    view profile

    Xiaojian Yao

    University of Manitoba, Canada
    view profile

    Seth Lederman

    TONIX Pharmaceuticals, USA
    view profile

    Winfried Stöcker

    Klin.med Lab, Germany

Donald A. Berry

M.D. Anderson Cancer Center of the University of Texas

USA

Bayesian Analyses for Adaptive Clinical Trial Designs: Application to Lecanemab Phase 2b Dose-finding Trial in Alzheimer Disease

Brandon Lucke-Wold

University of Florida

USA

Meta-analysis of direct endovascular thrombectomy vs bridging therapy in the management of acute ischemic stroke with large vessel occlusion

Xiaojian Yao

University of Manitoba

Canada

Dr. Xiaojian Yao, PhD and MD, Professor, is the director of the Laboratory of Molecular Human Retrovirology, in the Department of Medical Microbiology, Faculty of Medicine, University of Manitoba. He obtained his M.D., M.Sc., and Ph.D. degrees respectively at Suzhou Medical University, the National Institute for the Control of Pharma & Biol. products in China, and the University of Montreal. Dr. Yao’s research projects have been in the fundamental research to explore HIV and host protein interactions and their functional roles during HIV-1 replication, and the development of new approaches against HIV-1. In recent years, his lab has also focused on developing multivalent vaccines against high-risk viral pathogens, including HIV-1, SARS-CoV-2 and influenza A viruses.

Seth Lederman

TONIX Pharmaceuticals

USA

Seth Lederman is a physician, scientist, and the founder of Tonix. Prior to becoming a biopharma entrepreneur, Dr. Lederman served as an Associate Professor at Columbia University for two decades and directed basic science research in molecular immunology, infectious diseases and the development of therapeutics for autoimmune diseases. His fundamental work on the CD40-Ligand has led to the development of therapeutic candidates for autoimmune diseases and organ transplant rejection in collaboration with Biogen and UCB. Dr. Lederman earned his MD from Columbia University’s College of Physicians and Surgeons and an AB from Princeton in Chemistry cum laude.

Winfried Stöcker

Klin.med Lab

Germany

Winfried Stocker is a founder and director of EUROIMMUN, German physician, scientist, inventor and entrepreneur. In 1987 he founded the company Euroimmun , which he sold in 2017 for 1.2 billion euros. In 2013 he acquired the Görlitz department store as an investor and in 2016 the Lübeck-Blankensee Airport . Stöcker developed a vaccine against COVID-19 and administered it to the public despite the lack of approval . He also hit the headlines with polemical statements about migration policy and the MeToo debate

Contact Information

+1408-352-1010
ryan_cooper@vaccine-congress.org
+1408-352-1010

Locate US

5201 Great America Pkwy #320, Santa Clara, CA 95054, United States"

Keep me Updated..!


Copyrights © 2020-21 Innovinc International, All Rights Reserved